Content Type: Policy Interactions

Comments on Draft Guidance, “Considerations for the Use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause”

May 1, 2026

Brief of Law Scholars in Novartis v. Kennedy

April 15, 2026

Brief of Law Scholars in Boehringer Ingelheim v. Kennedy

April 15, 2026

Brief of Law Scholars in BMS v. Kennedy and Janssen v. Kennedy

April 15, 2026

Brief of Economists and Scholars of Health Policy in BMS v. Kennedy and Janssen v. Kennedy

April 15, 2026

Brief of Economists and Scholars of Health Policy in AstraZeneca v. Kennedy

April 15, 2026

Brief of Law Scholars in Novo Nordisk v. Kennedy

April 15, 2026

Brief of Economists and Scholars of Health Policy in National Infusion Center Association v. Kennedy (5th Circuit)

April 15, 2026

Brief of Law Scholars in Boehringer Ingelheim v. Becerra

April 14, 2026

Brief of Law Scholars in Dayton Area Chamber of Commerce v. Becerra

April 14, 2026

Brief of Law Scholars in Novartis v. Becerra

April 14, 2026

Brief of Economists and Scholars of Health Policy in Novo Nordisk v. Becerra

April 14, 2026